KR900007430A - 항-퓨코실세르아미드 모노클로날 항체 - Google Patents
항-퓨코실세르아미드 모노클로날 항체 Download PDFInfo
- Publication number
- KR900007430A KR900007430A KR1019890016069A KR890016069A KR900007430A KR 900007430 A KR900007430 A KR 900007430A KR 1019890016069 A KR1019890016069 A KR 1019890016069A KR 890016069 A KR890016069 A KR 890016069A KR 900007430 A KR900007430 A KR 900007430A
- Authority
- KR
- South Korea
- Prior art keywords
- cancer
- monoclonal antibody
- monoclonal antibodies
- fucosylseramide
- produce
- Prior art date
Links
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 claims description 2
- 229930186217 Glycolipid Natural products 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- 210000004408 hybridoma Anatomy 0.000 claims 4
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 3
- 210000004027 cell Anatomy 0.000 claims 3
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 3
- 201000002528 pancreatic cancer Diseases 0.000 claims 3
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 3
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 229940039227 diagnostic agent Drugs 0.000 claims 2
- 239000000032 diagnostic agent Substances 0.000 claims 2
- 206010017758 gastric cancer Diseases 0.000 claims 2
- 201000005202 lung cancer Diseases 0.000 claims 2
- 208000020816 lung neoplasm Diseases 0.000 claims 2
- 201000011549 stomach cancer Diseases 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 206010029260 Neuroblastoma Diseases 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 210000004102 animal cell Anatomy 0.000 claims 1
- 210000003743 erythrocyte Anatomy 0.000 claims 1
- 210000002950 fibroblast Anatomy 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 201000000050 myeloid neoplasm Diseases 0.000 claims 1
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 230000037029 cross reaction Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 중성 당지질 분획을 염색시킨 TLC 양상 및 퓨코실세르아미드(Fue-Cer)를 모노클로날 항체 PC47H로 면역 염색시킨 TLC양상을 나나탠 것이다.
제2도는 Fuc-Cer, Gal-Cer, 및 Glc-Cer와 모노클로날 항체 PC47H를 교차반응 분석한 결과이다.
Claims (8)
- 퓨코실세르아미드를 특이적으로 인식하는 모노클로날 항체.
- 제1항에 있어서, 모노클로날 항체가, a)Ig 분류에서 IgM에 속하고, b) 폐암, 위암, 결장암 및 췌장암에서 분리한 세포주와 반응성을 지니며, c) 정상 말초혈 림프구, 정상 적혈구 및 정상 섬유아세포와는 반응하지 않고, d) 백혈병, 간암, 유방암 및 신경아세포 종에서 분리한 세포주와는 반응하지 않는 특성을 지니는 모노클로날 항체.
- 제1항에 있어서, PC47H인 모노클로날 항체.
- 제1항, 2항 또는 3항의 모노클로날 항체를 생성하는 능력을 지닌 하이브리도마.
- 사람의 췌장암에서 추출한 중성 당지질 분획으로 동물을 면역시키고, 동물 세포와 골수종 세포를 융합시켜 하이브리도마를 생성시킨 후, 하이브리도마를 클론화 시키고, 퓨코실세르아미드를 특이적으로 인식하는 모노클로날 항체를 생성하는 클론을 선별한 후, 모노클로날 항체를 분리함을 특징으로 하여, 제1항, 2항 또는 3항의 모노클로날 항체를 제조하는 방법.
- 활성성분으로서 제1항, 2항 또는 3항으로 모노클로날 항체를 함유하는 암 진단용 진단제(diagnosticaid).
- 제6항에 있어서, 암이 폐암, 위암, 결장암 및 췌장암인 진단제.
- mab PC47H를 생성하는 하이브리도마 세포주 FERM BP-2557.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63281433A JPH02128697A (ja) | 1988-11-09 | 1988-11-09 | 抗フコシルセラミドモノクローナル抗体 |
JP63-281433 | 1988-11-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR900007430A true KR900007430A (ko) | 1990-06-01 |
Family
ID=17639099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890016069A KR900007430A (ko) | 1988-11-09 | 1989-11-07 | 항-퓨코실세르아미드 모노클로날 항체 |
Country Status (13)
Country | Link |
---|---|
US (1) | US5331093A (ko) |
EP (1) | EP0368222A1 (ko) |
JP (1) | JPH02128697A (ko) |
KR (1) | KR900007430A (ko) |
AU (1) | AU624440B2 (ko) |
CA (1) | CA2002530A1 (ko) |
DK (1) | DK557289A (ko) |
FI (1) | FI895287A0 (ko) |
IL (1) | IL92232A0 (ko) |
NO (1) | NO177311C (ko) |
NZ (1) | NZ231292A (ko) |
PT (1) | PT92235B (ko) |
ZA (1) | ZA898499B (ko) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998057179A1 (en) * | 1997-06-10 | 1998-12-17 | Medlyte Diagnostics, Inc. | Methods for early detection of heart disease |
AU781171B2 (en) * | 1997-06-10 | 2005-05-12 | Lpath Therapeutics, Inc. | Methods for early detection of heart disease |
KR100906789B1 (ko) * | 2006-04-03 | 2009-07-09 | 한국생명공학연구원 | 인간 신경전구체세포에 대한 단일클론항체 및 그의 이용 |
AU2008247368B2 (en) | 2007-05-06 | 2013-10-10 | Sloan Kettering Institute For Cancer Research | Methods for treating and preventing GI syndrome and Graft versus Host disease |
JP6219300B2 (ja) * | 2011-11-30 | 2017-10-25 | メタノミクス ヘルス ゲーエムベーハー | 膵臓癌を診断するための装置及び方法 |
EP3903820A1 (en) | 2012-05-25 | 2021-11-03 | Sloan-Kettering Institute for Cancer Research | An anti-ceramide antibodies |
EP3597758A1 (en) * | 2013-04-29 | 2020-01-22 | AgroSavfe nv | Agrochemical compositions comprising polypeptides |
US20150231077A1 (en) | 2014-02-17 | 2015-08-20 | The Cleveland Clinic Foundation | Amine passivated nanoparticles for cancer treatment and imaging |
SG11201700787XA (en) | 2014-08-07 | 2017-02-27 | Sloan Kettering Inst Cancer | Anti-ceramide antibodies |
EP3081938A1 (en) * | 2015-04-13 | 2016-10-19 | Johann Wolfgang Goethe-Universität Frankfurt am Main | Serum biomarker for hepatocellular carcinoma (hcc) |
-
1988
- 1988-11-09 JP JP63281433A patent/JPH02128697A/ja active Pending
-
1989
- 1989-11-07 FI FI895287A patent/FI895287A0/fi not_active Application Discontinuation
- 1989-11-07 NZ NZ231292A patent/NZ231292A/en unknown
- 1989-11-07 IL IL92232A patent/IL92232A0/xx not_active IP Right Cessation
- 1989-11-07 KR KR1019890016069A patent/KR900007430A/ko not_active Application Discontinuation
- 1989-11-07 EP EP89120549A patent/EP0368222A1/en not_active Withdrawn
- 1989-11-08 DK DK557289A patent/DK557289A/da not_active Application Discontinuation
- 1989-11-08 CA CA002002530A patent/CA2002530A1/en not_active Abandoned
- 1989-11-08 ZA ZA898499A patent/ZA898499B/xx unknown
- 1989-11-08 PT PT92235A patent/PT92235B/pt not_active IP Right Cessation
- 1989-11-08 NO NO894444A patent/NO177311C/no unknown
- 1989-11-09 AU AU44503/89A patent/AU624440B2/en not_active Ceased
-
1992
- 1992-05-27 US US07/888,306 patent/US5331093A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU624440B2 (en) | 1992-06-11 |
NO894444D0 (no) | 1989-11-08 |
IL92232A0 (en) | 1990-07-26 |
NO177311C (no) | 1995-08-23 |
NO177311B (no) | 1995-05-15 |
DK557289A (da) | 1990-05-10 |
NO894444L (no) | 1990-05-10 |
DK557289D0 (da) | 1989-11-08 |
US5331093A (en) | 1994-07-19 |
EP0368222A1 (en) | 1990-05-16 |
FI895287A0 (fi) | 1989-11-07 |
JPH02128697A (ja) | 1990-05-17 |
PT92235A (pt) | 1990-05-31 |
AU4450389A (en) | 1990-05-17 |
PT92235B (pt) | 1995-07-06 |
ZA898499B (en) | 1990-08-29 |
NZ231292A (en) | 1992-05-26 |
CA2002530A1 (en) | 1990-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Van Lier et al. | Induction of T cell proliferation with anti‐CD3 switch‐variant monoclonal antibodies: effects of heavy chain isotype in monocyte‐dependent systems | |
NZ217829A (en) | Monoclonal anti-human breast cancer antibodies and test reagent | |
ATE58554T1 (de) | Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper. | |
EP0189688A3 (en) | Monoclonal antibody capable of recognizing arteriosclerotic lesions and agents for detecting and treating arteriosclerosis | |
US5185432A (en) | Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas | |
KR900007430A (ko) | 항-퓨코실세르아미드 모노클로날 항체 | |
EP0124717A3 (en) | Human monoclonal antibodies to cancer cells | |
DE3581288D1 (de) | Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen. | |
DK0466818T3 (da) | Monoklonalt antistof der genkender et glycoprotein fra mucin-antigen fra membranen af fedtkugler fra human mælk | |
Peault et al. | Tissue distribution and ontogenetic emergence of differentiation antigens on avian T cells | |
EP0184369A3 (en) | Monoclonal antibody specific for a mammary tumor cell surface antigen | |
DK13485D0 (da) | Hybridomacellelinie og monoklonalt antistof opnaaet ved hjaelp af en saadan cellelinie | |
EP0155172A3 (en) | Anti-human lung cancer monoclonal antibodies | |
EP0184370A3 (en) | Monoclonal antibody specific for a mammary tumor cytoplasmic antigen | |
NO174005C (no) | Monoklonalt antistoff, hybridom, og reagens for immunologisk analyse av x-hANP | |
Van Camp et al. | Transient IgA1-λ paraproteinemia during treatment of acute myelomonoblastic leukemia | |
Takei | MALA-1: a surface antigen expressed on activated murine T and B lymphocytes. | |
KR930019820A (ko) | 모노클로날 항-강글리오사이드 항체, 이의 제조방법 및 종양 치료제로서의 용도 | |
FR2571146B1 (fr) | Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant | |
EP0141616A3 (en) | Hybrid cell lines producing monoclonal antibodies directed against trichomonas vaginalis determinants | |
US5232832A (en) | Antibody reactive to hamster immunoglobulins and assay using same | |
WO1987007302A3 (en) | MONOCLONAL ANTIBODIES TO HUMAN LYMPHOCYTE IgE RECEPTORS, HYBRIDOMAS PRODUCING SUCH ANTIBODIES, AND KITS FOR USING SUCH ANTIBODIES | |
EP0293262A3 (en) | Monoclonal antibodies which recognize human intestinal cancer cells, corresponding hybridomas, their preparation and use | |
Sonnenberg et al. | Monoclonal antibodies detecting different epitopes on the Forssman glycolipid hapten. | |
DE3579808D1 (de) | Anti-urokinase monoklonaler antikoerper, seine herstellung und verwendung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |